A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis

PURPOSE: Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) is common and is the second most common cause of death. Clinical studies regarding chemotherapy for CRC with PC have been classically rather limited in scope. We evaluated the efficacy of modified oxaliplatin, leucovorin, and fluorou...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lee, Dong Hyun, Oh, Sung Yong, Lee, Yu Rim, Huh, Seok Jae, Yoon, Hyun Hwa, Kim, Sung Hyun, Lee, Suee, Lee, Ji Hyun, Kim, Young, Kim, Hyo-Jin, Kwon, Hyuk-Chan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Cancer Association 2011
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3253864/
https://ncbi.nlm.nih.gov/pubmed/22247707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2011.43.4.225
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia